Product Search
News
The Nitto website is currently under system maintenance.
Please try again later.
Please try again later.
- 2019/Dec/25
- 2020/Jan/27 Announcement of Financial Results for 3Q, FY2019
- 2019/Dec/03
- Establishment of the Tokyo Head Office and Consolidation with the Tokyo Sales Branch
- 2019/Oct/28
- Announcement of Financial Results 2Q, FY2019
- 2019/Oct/23
- Notice of Revisions to the Consolidated Financial Forecasts
- 2019/Sep/25
- 2019/Oct/28 Announcement of Financial Results for 2Q, FY2019
The Nitto website is currently under system maintenance.
Please try again later.
Please try again later.
- 2019/Dec/03
- Establishment of the Tokyo Head Office and Consolidation with the Tokyo Sales Branch
- 2019/Jul/19
- Alliance with Drug Discovery Gateway Investment Limited Partnership to Accelerate the Commercialization of the New Transdermal Therapeutic System (“PassPort System”)
- 2019/Jun/18
- Sumitomo Dainippon Pharma and Nitto Denko Announce the Approval of Atypical Antipsychotic LONASEN® Tape in Japan
- 2019/Jun/07
- Launch of Bisono® Tape 2mg, a Transdermal Patch Containing a β1 Blocker
- 2019/Apr/18
- Established a Collaborative Research Department for the Development of New Nucleic Acid Drugs
